Tomas
Ruiz Albi
Instituto de Salud Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Salud Carlos III (1)
2022
-
N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study
Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5